Biocrede, Inc.

Ann Arbor, MI 48104

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.17MM
First Award Date 09/15/13
Most Recent Award Date 09/01/16

Key Personnel

Last Name Name Awards Contact
Chen Hao Chen 6
Meyerhoff Mark E Meyerhoff 5
Roy-Chaudhury Prabir Roy-Chaudhury 1
XI CHUANWU XI 1

6 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-13-051
Budget: 09/01/16 - 08/31/17

? DESCRIPTION (provided by applicant): In Phase I, Biocrede developed a completely new urinary tract silicone Foley catheter with a >4.5 month shelf-life, made from a proprietary polymeric formulation to effectively reduce catheter-associated urinary tract infections (CAUTI) via nitric oxide (NO) release for >2 weeks. Key features of the new ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 05/01/16 - 04/30/17
PI: Hao Chen

? DESCRIPTION (provided by applicant): Our product will monitor intravenous (IV) blood lactate levels (for >7 days) of critical ill patients with sepsis, organ failure, trauma, or acute inflammatory response in the ICU, and infant patients with congenital heart disease (CHD) recovering from cardiopulmonary bypass (CPB) surgery. This device wil...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-13-051
Budget: 09/01/15 - 08/31/16

DESCRIPTION (provided by applicant): In Phase I, Biocrede developed a completely new urinary tract silicone Foley catheter with a >4.5 month shelf-life, made from a proprietary polymeric formulation to effectively reduce catheter-associated urinary tract infections (CAUTI) via nitric oxide (NO) release for >2 weeks. Key features of the new techn...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-050
Budget: 09/15/14 - 08/31/15
PI: Hao Chen

DESCRIPTION (provided by applicant): We propose a completely new, low cost and robust bactericidal urinary 100% silicone Foley catheter with a >3-6 month shelf-life, that will utilize electromodulated delivery of nitric oxide (NO) for up to 45-60 d to serve as a potent antimicrobial/antibiofilm agent. The first generation device will possess a s...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-13-051
Budget: 09/19/13 - 08/31/14
PI: Hao Chen

DESCRIPTION (provided by applicant): We propose a novel and price competitive Tunneled Dialysis Catheter (TDC) made from a proprietary polymeric formulation to effectively reduce TDC dysfunction via long-term nitric oxide (NO) release, particularly during the period of AVF maturation in incident hemodialysis and TDC dependent patients. Prelimina...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 09/15/13 - 08/31/14
PI: Hao Chen

DESCRIPTION (provided by applicant): We propose a novel and competitive urinary tract silicone Foley catheter made from a proprietary polymeric formulation to effectively reduce catheter-associated urinary tract infections (CAUTI) via nitric oxide (NO) release. Preliminary studies show that the device will be able to: (1) continuously deliver NO...